Can endoscopy protect against colorectal cancer? An RCT

The Lancet

Volumn 375, Issue 9726, 2010, Pages 1582-1584

  Ransohoff, David F ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD EXAMINATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; HUMAN; OCCULT BLOOD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SIGMOIDOSCOPY;

EID: 77951877743     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60626-5     Document Type: Note

References (12)

1. Selby J.V., Friedman G.D., Quesenberry Jr. C.P., and Weiss N.S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326 (1992) 653-657
2. Winawer S.J., Zauber A.G., Ho M.N., et al., for the National Polyp Study Workgroup. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 329 (1993) 1977-1981
3. Ransohoff D.F. Have we oversold colonoscopy?. Gastroenterology 129 (2005) 1815
4. Atkin W.S., Edwards R., Kralj-Hans I., et al., UK Flexible Sigmoidoscopy Trial Investigators. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet (2010) 10.1016/S0140-6736(10)60551-X published online April 28.
5. Hoff G., Grotmol T., Skovlund E., Bretthauer M., and for the Norwegian Colorectal Cancer Prevention Study Group. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 338 (2009) b1846
6. Prorok P.C., Andriole G.L., Bresalier R.S., et al., for the Prostate Lung Colorectal and Ovarian Cancer Screening Trial Project Team. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 21 suppl 6 (2000) 273S-309S
7. Baxter N.N., Goldwasser M.A., Paszat L.F., Saskin R., Urbach D.R., and Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 150 (2009) 1-8
8. Brenner H., Hoffmeister M., Arndt V., Stegmaier C., Altenhofen L., and Haug U. Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst 102 (2010) 89-95
9. Anon. The Northern-European Initiative on Colorectal Cancer (NordICC). http://clinicaltrials.gov/ct2/show/NCT00883792 (accessed April 12, 2010).
10. Pignone M., Saha S., Hoerger T., and Mandelblatt J. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137 (2002) 96-104
11. Pignone M, Russell L, Wagner J, eds. Economic models of colorectal cancer screening in average-risk adults: workshop summary. 2005. http://www.nap.edu/catalog/11228.html (accessed April 23, 2010).
12. Morikawa T., Kato J., Yamaji Y., Wada R., Mitsushima T., and Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129 (2005) 422-428